Company registration number:
09074555
CSK Therapeutics Ltd
Unaudited filleted financial statements
31 March 2025
CSK Therapeutics Ltd
Contents
Directors and other information
Statement of financial position and notes to the financial statements
CSK Therapeutics Ltd
Directors and other information
|
|
|
|
Director |
Dr Amit Nathwani |
|
|
|
|
|
|
|
Company number |
09074555 |
|
|
|
|
|
|
|
Registered office |
The Stables Timberdene Loudwater Drive, |
|
|
Loudwater, Rickmansworth, |
|
|
Herts, |
|
|
England |
|
|
WD3 4HJ |
|
|
|
|
|
|
|
Accountants |
Nagle James Associates Limited |
|
|
Amba House, 4th Floor |
|
|
Kings Suite |
|
|
15 College Road |
|
|
Harrow, Middlesex |
|
|
HA1 1BA |
|
|
|
CSK Therapeutics Ltd
Statement of financial position
31 March 2025
|
|
|
31/03/25 |
|
31/03/24 |
|
|
|
|
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
18,425 |
|
24,567 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
(
3,607) |
|
(
2,069) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Net current liabilities |
|
|
(
3,607) |
|
(
2,069) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
14,818 |
|
22,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Net assets |
|
|
14,818 |
|
22,498 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
14,818 |
|
22,498 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
Notes to the financial statements
CSK Therapeutics Ltd
Year ended 31 March 2025
1.
Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2024: Nil).
2.
Directors advances, credits and guarantees
|
During the year the director entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended 31/03/25 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the director |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Dr Amit Nathwani |
(
2,069) |
(
1,538) |
(
3,607) |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
|
Period ended 31/03/24 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the director |
Balance o/standing |
|
|
|
|
|
£ |
£ |
£ |
|
|
|
|
Dr Amit Nathwani |
(
394) |
(
1,675) |
(
2,069) |
|
|
|
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The director acknowledges responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
26 November 2025
, and are signed on behalf of the board by:
Dr Amit Nathwani
Director
Company registration number:
09074555
The company is a private company limited by shares, registered in England & Wales.